[189 Pages Report] The Enteric Disease Testing Market size was estimated at USD 4.31 billion in 2023 and expected to reach USD 4.54 billion in 2024, at a CAGR 5.47% to reach USD 6.26 billion by 2030.
Enteric disease testing encompasses a variety of diagnostic procedures aimed at identifying pathogens that cause infectious diseases affecting the gastrointestinal tract. Given the critical role of early and accurate diagnosis in managing and preventing the spread of these diseases, the need for enteric disease testing is driven by factors such as the growing global prevalence of enteric diseases, advancements in diagnostic technologies, and increased awareness and healthcare spending. However, the practice faces challenges such as the high costs associated with advanced testing technologies, limited accessibility in low-resource settings, and the need for skilled personnel to conduct and interpret tests. To address these issues, there is an ongoing focus on developing cost-effective and user-friendly diagnostic solutions that can be deployed widely, including in resource-constrained environments. The integration of molecular diagnostics, point-of-care testing, and the application of artificial intelligence and machine learning to improve test accuracy and speed is expected to diversify the testing procedures.
Disease Type: Increasing preference for multiplex and molecular diagnostic methods for bacterial testing
Bacterial enteric diseases, such as Salmonella, Shigella, and Escherichia coli (E. coli) infections, are major causes of gastrointestinal infections globally. These conditions necessitate precise diagnostic tools for prompt identification and treatment. High specificity and sensitivity assays are preferred for bacterial enteric disease testing to minimize false positives and negatives. Parasitic enteric diseases caused by organisms such as Giardia lamblia, Cryptosporidium, and Entamoeba histolytica pose significant diagnostic challenges due to their complex life cycles and the varying sensitivity and specificity of detection methods. Diagnostic tests for parasitic infections need to offer comprehensive coverage for multiple parasites due to the overlapping symptoms of different parasitic diseases. Viral enteric diseases, including infections caused by Norovirus, Rotavirus, and Hepatitis A, are widespread and often lead to outbreaks, particularly in communal settings and lower-income countries. Rapid, accurate, and scalable diagnostic methods are critical for managing viral enteric diseases.
Testing Site: Need for rapid diagnostics crucial for immediate patient care in hospitals
In-hospital testing involves diagnostic procedures conducted within a hospital setting, typically in the pathology or microbiology departments. This segment caters primarily to patients already admitted to the hospital or those visiting the outpatient department. The need for in-hospital testing is driven by the requirement for immediate diagnostic results to initiate treatment, especially in severe cases of enteric diseases. Point-of-care (PoC) testing for enteric diseases is characterized by the delivery of diagnostics in close proximity to the location of patient care, such as clinics, physician offices, or in the field during outbreaks. The primary need for PoC testing stems from its convenience, rapid result generation, and the enabling of timely decision-making in treatment. Standalone laboratories refer to independent facilities specializing in a wide array of diagnostic tests, including those for enteric diseases. This segment caters to healthcare providers without in-house diagnostic capabilities and direct-to-consumer testing services.
Regional Insights
In the Americas, especially the United States and Canada, there is a high adoption rate of advanced diagnostic solutions, including molecular diagnostics and point-of-care testing, driven by robust healthcare systems and high healthcare expenditure. Companies in this region benefit from a conducive regulatory environment and significant investment in R&D, leading to rapid innovation and production of enteric disease testing solutions. The APAC region has a growing demand for enteric disease diagnostics due to increasing awareness of diseases such as cholera and typhoid coupled with rising healthcare spending. However, the market is characterized by a mix of advanced and traditional diagnostic practices, with significant variations in healthcare infrastructure across countries. Production in APAC is growing, with local companies emerging alongside established global players. EMEA presents a diverse picture, with highly developed markets in Western Europe employing cutting-edge diagnostic technologies while countries in Africa and parts of the Middle East grapple with challenges related to access and affordability of enteric disease testing. Regulatory environments across EMEA vary widely, affecting the pace of adoption of new technologies. Companies operating in EMEA are balancing innovation with cost-effective production to meet the needs of a diverse patient population.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Enteric Disease Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Enteric Disease Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Enteric Disease Testing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Als Limited, Asure Quality, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerica Inc., bioM?rieux SA, Bureau Veritas Group, Cepheid Inc., Coris BioConcept SPRL, DiaSorin, Eurofins Scientific SE, Hardy Diagnostics, Intertek Group PLC, Merck & Co., Inc., Merck KGAA, Meridian Bioscience Inc., M?rieux NutriSciences Corporation, Neogen Corporation, Nova Biologicals, Perkinelmer, Inc., Qiagen N.V., Quest Diagnostics, Romer Labs Division Holding GmbH, SGS SA, Symbio Laboratories, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and T?V S?D AG.
Market Segmentation & Coverage
This research report categorizes the Enteric Disease Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Product
- Consumables
- Kits
- Reagents
- Disease Type
- Bacterial
- Cholera
- Escherichia coli
- Salmonellosis
- Parasitic
- Viral
- Bacterial
- Diagnostic Techniques
- Immunoassays
- Molecular Diagnostics
- PCR
- Real-time PCR
- Rapid Diagnostics
- Dipsticks
- Lateral Flow Assays
- Testing Site
- In-Hospital
- Point-of-Care
- Standalone Laboratories
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Enteric Disease Testing Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Enteric Disease Testing Market?
- What are the technology trends and regulatory frameworks in the Enteric Disease Testing Market?
- What is the market share of the leading vendors in the Enteric Disease Testing Market?
- Which modes and strategic moves are suitable for entering the Enteric Disease Testing Market?
US $
Euro €
GBP £